Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Degrees

Harvard Medical School, PhD 2004
Genetics, Molecular and Cell Biology
Rutgers College, BA 1999
Biology

Current Companies

Board of Directors
Director
Director
Director
Board Observer
Director
Director
Board Of Directors
Show All Companies

Former Companies

Financial Organizations

Web Presences

Tags

Kevin Bitterman

Kevin is the interim president of Editas Medicine and a principal at Polaris Partners. He joined Polaris in 2004 and focuses on investments in health care.

Kevin is a co-founder of Genocea Biosciences and Sirtris Pharmaceuticals (acquired by GSK) and was the founding CEO at Visterra Inc. (formerly Parasol Therapeutics).

He currently represents Polaris as a director of InSeal Medical, Genocea Biosciences, Kala Pharmaceuticals, Neuronetics, Inc., Visterra Inc., Taris Biomedical and Vets First Choice.

Additionally, he is a board observer to Arsenal Medical and 480 Biomedical.

Kevin holds a Ph.D. in genetics from Harvard Medical School. His doctoral research focused on the molecular regulation of caloric restriction and on modulation of a novel class of protein deacetylases.

Recent Milestones

Videos

Sources

Edit This Page
Last Edited 4/2/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy